Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancer - Concepedia

Concepedia

Publication | Open Access

Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancer

DOI Full Paper Access

10

Citations

18

References

2021

Year

Jun Liang, Jun Li, Robert A. Blake, Jae H. Chang, Lori S. Friedman, Simon Goodacre, Steven J. Hartman, Ellen Ingalla, James R. Kiefer, Tracy Kleinheinz,

Bioorganic & Medicinal Chemistry Letters

Potent DegraderBreast OncologyEndocrine-related CancerMedicineHormonal ReceptorPharmacologyBreast CancerAnti-cancer AgentOncologyRadiation OncologyCancer ResearchDrug Discovery

References

	Year	Citations

Page 1

Page 1